Quantum Biopharma Ltd. (QNTM) Operating Income (2019 - 2026)

Quantum Biopharma (QNTM) has 8 years of Operating Income data on file, last reported at -$3.0 million in Q1 2026.

• Quarterly Operating Income rose 12.69% year-over-year to -$3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14.9 million (down 13.29% YoY) and the FY2025 annual result came in at -$15.3 million, up 5.17% from the prior year.
• Operating Income fell to -$3.0 million in Q1 2026 per QNTM's latest filing, from -$2.4 million in the prior quarter.
• The five-year high for Operating Income was $5.6 million in Q1 2022, with the low at -$9.8 million in Q1 2023.
• Average Operating Income over 5 years is -$3.1 million, with a median of -$3.4 million recorded in 2023.
• Year-over-year, Operating Income sank 274.26% in 2023 and jumped 77.07% in 2024.
• Quantum Biopharma's Operating Income stood at $5.6 million in 2022, then tumbled by 158.62% to -$3.3 million in 2023, then jumped by 36.85% to -$2.1 million in 2024, then decreased by 13.48% to -$2.4 million in 2025, then slipped by 24.98% to -$3.0 million in 2026.
• Business Quant data shows QNTM's Operating Income at -$3.0 million in Q1 2026, -$2.4 million in Q4 2025, and -$4.7 million in Q3 2025.